c-MYC responds to glucose deprivation in a cell-type-dependent manner

Metabolic reprogramming supports cancer cells’ demands for rapid proliferation and growth. Previous work shows that oncogenes, such as MYC, hypoxia-inducible factor 1 (HIF1), have a central role in driving metabolic reprogramming. A lot of metabolic enzymes, which are deregulated in most cancer cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, S, Yin, X, Fang, X, Zheng, J, Li, L, Liu, X, Chu, L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979460/
https://www.ncbi.nlm.nih.gov/pubmed/27551483
http://dx.doi.org/10.1038/cddiscovery.2015.57

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979460/
https://www.ncbi.nlm.nih.gov/pubmed/27551483
http://dx.doi.org/10.1038/cddiscovery.2015.57

Ejemplares similares